Live Breaking News & Updates on Scientist Individual Research Grant

Vela Diagnostics Announces Collaboration with the National Cancer Centre of Singapore to Refine Novel Cancer Therapy
USA - English
Share this article
Share this article
SINGAPORE, June 3, 2021 /PRNewswire/ Vela Diagnostics announced a collaboration with the National Cancer Centre of Singapore (NCCS) to develop a molecular diagnostic assay to predict individual patients responses to a cancer therapy called Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs). Being able to predict an individual s response will help clinicians determine if EGFR-TKIs are a suitable therapeutic option for the patient. The partnership between Vela Diagnostics and NCCS aims to refine the therapeutic management of cancer to improve clinical outcomes. ....

Charlie Lee , Gopal Iyer , Head Of Research , National Cancer Centre Of Singapore , Scientist Individual Research Grant , Head Of The Division Medical Sciences , Neck Centre , Division Of Medical Oncology , Singapore Translational Cancer Consortium , Epidemiological Services , National Cancer Centre , Epidermal Growth Factor Receptor , Vela Diagnostics , Nature Medicine , Professor Gopal Iyer , Associate Professor Daniel Tan , Prof Gopal Iyer , Medical Sciences , Senior Consultant , Assoc Prof Daniel Tan , Deputy Head , Clinical Trials , Medical Oncology , Singapore Ministry , National Medical Research Council , Clinician Scientist Individual Research Grant ,